Prevalence of sleep deficiency and use of hypnotic drugs in astronauts before, during, and after spaceflight: an observational study.
Laura K Barger, Erin E Flynn-Evans, Alan Kubey...
https://pubmed.ncbi.nlm.nih.gov/25127232Actively Recruiting
Led by National Aeronautics and Space Administration (NASA) · Updated on 2024-08-01
24
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how different sleep and wake-promoting methods affect the ability to fall asleep quickly, maintain sleep during a nap, and stay alert while awake. The study focuses on testing pink noise during sleep and blue-enriched lighting combined with a nap to see if these interventions improve sleep quality and alertness. This study recruits healthy adults aged 18 to 60 and involves controlled laboratory conditions to minimize bias related to time awareness. Participants will take part in two laboratory visits spaced at least one week apart, after completing a 2-3 week at-home protocol maintaining a regular sleep schedule with at least 8.5 hours in bed each night. They will be randomly assigned to one of three groups: sleep promoting with pink noise plus wake placebo, sleep placebo plus wake promoting with blue-enriched light and a nap, or both sleep promoting and wake promoting. Each participant will experience both an intervention condition and a full placebo condition across the two visits. During each lab visit, participants will be monitored with EEG for sleep stages and quality, and undergo multiple tests including the Karolinska Sleepiness Scale (KSS) for subjective alertness, the psychomotor vigilance task (PVT) for cognitive performance, and saliva sample collection for circadian rhythm markers. Testing occurs hourly except during sleep, and participants will be observed to prevent unplanned sleep. The study includes temperature and vital sign monitoring, provides meals based on preferences, and requires participants not to drive after visits. Total lab time per visit is about 25 hours, with extensive monitoring and evaluation of sleep and alertness outcomes.
CONDITIONS
Artemis Sleep Countermeasures
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Duration - Approximately 25 hours
Participants spend 25 hours in the laboratory undergoing randomized interventions including a daytime sleep opportunity with pink noise or silence, followed by a nighttime nap or quiet activities, and exposure to blue-enriched or placebo lighting. During this time, participants complete various cognitive and alertness tests and provide biological samples.
1 in-person visit lasting about 25 hours
Duration - Until recovery post-study
After completing the laboratory session, participants are sent home and advised to nap and avoid driving or risky activities until recovered from study-induced sleep deprivation.
No scheduled visits; recovery occurs at home
Total: 1 location
1
NASA Ames Research Center
Mountain View, California, United States, 94043
Actively Recruiting
E
Erin E Flynn-Evans, PhD, MPH
N
Nicholas G Bathurst, MA
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Laura K Barger, Erin E Flynn-Evans, Alan Kubey...
https://pubmed.ncbi.nlm.nih.gov/25127232Mathias Basner, David F Dinges
https://pubmed.ncbi.nlm.nih.gov/21532951Mathias Basner, Adam Savitt, Tyler M Moore...
https://pubmed.ncbi.nlm.nih.gov/26564759A A Borbély
https://pubmed.ncbi.nlm.nih.gov/7185792Timothy M Brown, George C Brainard, Christian Cajochen...
https://pubmed.ncbi.nlm.nih.gov/35298459Larry Cahill, Lukasz Gorski, Kathryn Le
https://pubmed.ncbi.nlm.nih.gov/12888545Elizabeth Capezuti, Kevin Pain, Evelyn Alamag...
https://pubmed.ncbi.nlm.nih.gov/34964434Claire C Caruso
https://pubmed.ncbi.nlm.nih.gov/23780784C A Czeisler, J F Duffy, T L Shanahan...
https://pubmed.ncbi.nlm.nih.gov/10381883C A Czeisler, J J Gooley
https://pubmed.ncbi.nlm.nih.gov/18419318